Source comparison
Real Peptides MOTS-c vs Competitors Quality — Purity Test
Most peptide suppliers claim 'research-grade' quality. Fewer than 15% back that claim with independent third-party certificates of analysis on every batch. The difference isn't academic. A MOTS-c peptide synthesized at 92% purity instead of 98% can skew mitoch
This comparison does not assign a generated winner or score.
- Most peptide suppliers claim 'research-grade' quality. Fewer than 15% back that claim with independent third-party certificates of analysis on every batch. The difference isn't academic. A MOTS-c peptide synthesized at 92% purity instead of 98% can skew mitochondrial function assays, introduce impurities that interfere with receptor binding, and generate inconsistent dose-response curves across replicate studies. Real Peptides produces MOTS-c through small-batch synthesis with verified amino-acid sequencing and batch-specific COAs confirming ≥98% purity. Competitors selling at half the price often skip the independent validation step entirely.
- Our team works directly with research institutions running mitochondrial studies, metabolic assays, and aging interventions. We've reviewed hundreds of peptide specifications from competing suppliers. The single clearest pattern: suppliers who don't publish COAs publicly are the ones whose internal testing fails to meet pharmaceutical-grade thresholds.
- What is MOTS-c quality, and why does purity matter in research applications?
- MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a mitochondrial-derived peptide with a 16-amino-acid sequence that regulates metabolic homeostasis and insulin sensitivity. Research-grade MOTS-c quality is defined by three measurable factors: purity (percentage of the target peptide vs impurities), sequence fidelity (correct amino-acid order without deletions or substitutions), and stability (resistance to degradation under standard storage conditions). Purity below 95% introduces truncated peptides, deletion sequences, and synthesis byproducts that bind to off-target receptors. Compromising experimental validity and reproducibility across labs.
- The term 'research-grade' has no regulatory definition. Any supplier can print it on a label. What distinguishes Real Peptides MOTS-c from competitors isn't the marketing claim. It's the third-party verification published with every batch and the small-batch synthesis model that prioritizes sequence accuracy over production volume. The rest of this piece covers how peptide purity is tested, what specific impurities to watch for in MOTS-c formulations, and why batch-level COA validation matters more than supplier reputation alone.